Reconciliation Action Plan Progress Summary Q1 & Q2 2019

Today GSK distinguishes itself not only through its innovative and commercial success but also through a collective ethical approach to all areas of business. As one of the largest pharmaceutical companies in the world, we understand our great responsibility to all our stakeholders, including Indigenous Australians.

In 2018 we launched our second Reconciliation Action Plan to build upon the success of the first Plan which marked GSK’s recognition of Aboriginal and Torres Strait Islander peoples and helped shape our efforts to close the life expectancy gap between Indigenous and non-Indigenous Australians. Our RAP is championed by the Australian Executive Team and the National Reconciliation Committee (NRC). The NRC consists of senior members across our Australian businesses and will lead sub-committees within both our Abbotsford head office, Consumer Healthcare business in Sydney and manufacturing site in Boronia.

To demonstrate that we're not just talking the talk but actually walking the walk, we have released a Progress Summary Report. This document provides details of the actions taken towards our Reconciliation Action Plan deliverables in the first half of 2019. 

See the report here:

While we have made significant progress, there is still much more to be done. See details of our onging commitment to to making a tangible difference in the nation’s reconciliation journey here: 

Related tags

Back to top